Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria

被引:12
|
作者
Ho, Soo Yei [1 ]
Wang, Weiling [1 ]
Ng, Fui Mee [1 ]
Wong, Yun Xuan [1 ]
Poh, Zhi Ying [1 ]
Tan, Sum Wai Eldwin [1 ]
Ang, Shi Hua [1 ]
Liew, Si Si [1 ]
Wong, Yin Sze Joyner [1 ]
Tan, Yvonne [1 ]
Poulsen, Anders [1 ]
Pendharkar, Vishal [1 ]
Sangthongpitag, Kanda [1 ]
Manchester, John [2 ,3 ]
Basarab, Gregory [2 ,4 ]
Hill, Jeffrey [1 ]
Keller, Thomas H. [1 ]
Cherian, Joseph [1 ]
机构
[1] Expt Therapeut Ctr, 13 Biopolis Way, Nanos 13866, Singapore
[2] AstraZeneca, 35 Gatehouse Dr, Waltham, MA 02451 USA
[3] Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA
[4] Univ Cape Town, Dept Chem, H3D,PD Hahn Bldg,Upper Campus, ZA-7700 Rondebosch, South Africa
关键词
Gram-negative bacteria; Dual target inhibition; Gyrase B; ParE; Gyrase; TopoIV; TOPOISOMERASE-IV PARE; PSEUDOMONAS-AERUGINOSA; DNA; SUBUNIT; AVIBACTAM; SPECTRUM; BROAD; GYRB;
D O I
10.1016/j.ejmech.2018.08.025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Even though many GyrB and ParE inhibitors have been reported in the literature, few possess activity against Gram-negative bacteria. This is primarily due to limited permeability across Gram-negative bacterial membrane as well as bacterial efflux mechanisms. Permeability of compounds across Gramnegative bacterial membranes depends on many factors including physicochemical properties of the inhibitors. Herein, we show the optimization of pyridylureas leading to compounds with potent activity against Gram-negative bacterial species such as P.aeruginosa, E.coli and A.baumannii. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:610 / 621
页数:12
相关论文
共 50 条
  • [1] Computational analysis and synthesis of potential inhibitors active against Gram-negative bacteria
    Roldan, Rebeca
    Pajarillo, Andrea
    Embry, Carter
    Cafiero, Mauricio
    Peterson, Larryn
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [2] Update on the Discovery of Efflux Pump Inhibitors against Critical Priority Gram-Negative Bacteria
    Compagne, Nina
    Da Cruz, Anais Vieira
    Mueller, Reinke T.
    Hartkoorn, Ruben C.
    Flipo, Marion
    Pos, Klaas M.
    ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [3] Discovery of Novel Inhibitors of LpxC Displaying Potent in Vitro Activity against Gram-Negative Bacteria
    Surivet, Jean-Philippe
    Panchaud, Philippe
    Specklin, Jean-Luc
    Diethelm, Stefan
    Blumstein, Anne-Catherine
    Gauvin, Jean-Christophe
    Jacob, Loic
    Masse, Florence
    Mathieu, Gaelle
    Mirre, Azely
    Schmitt, Christine
    Lange, Roland
    Tidten-Luksch, Naomi
    Gnerre, Carmela
    Seeland, Swen
    Herrmann, Charlyse
    Seiler, Peter
    Enderlin-Paput, Michel
    Mac Sweeney, Aengus
    Wicki, Micha
    Hubschwerlen, Christian
    Ritz, Daniel
    Rueedi, Georg
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (01) : 66 - 87
  • [4] Utilizing triazole-based compounds as potential inhibitors active against gram-negative bacteria
    Roldan, Rebeca
    Embry, Carter
    Peterson, Larryn
    Cafiero, Mauricio
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [5] Gramicidin S is active against both gram-positive and gram-negative bacteria
    Kondejewski, LH
    Farmer, SW
    Wishart, DS
    Hancock, REW
    Hodges, RS
    INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1996, 47 (06): : 460 - 466
  • [6] NEW POLYENIC ANTIBIOTICS ACTIVE AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA
    WATANABE, T
    SUGIYAMA, T
    TAKAHASHI, M
    SHIMA, J
    YAMASHITA, K
    IZAKI, K
    FURIHATA, K
    SETO, H
    JOURNAL OF ANTIBIOTICS, 1992, 45 (04): : 470 - 475
  • [7] Inhibitors targeting BamA in gram-negative bacteria
    Storek, Kelly M.
    Sun, Dawei
    Rutherford, Steven T.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2024, 1871 (01):
  • [8] Inhibitors of efflux pumps in Gram-negative bacteria
    Pagès, JM
    Masi, M
    Barbe, J
    TRENDS IN MOLECULAR MEDICINE, 2005, 11 (08) : 382 - 389
  • [9] Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: Development of inhibitors with broad spectrum, Gram-negative antibacterial activity
    Trzoss, Micheal
    Bensen, Daniel C.
    Li, Xiaoming
    Chen, Zhiyong
    Thanh Lam
    Zhang, Junhu
    Creighton, Christopher J.
    Cunningham, Mark L.
    Kwan, Bryan
    Stidham, Mark
    Nelson, Kirk
    Brown-Driver, Vickie
    Castellano, Amanda
    Shaw, Karen J.
    Lightstone, Felice C.
    Wong, Sergio E.
    Nguyen, Toan B.
    Finn, John
    Tari, Leslie W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (05) : 1537 - 1543
  • [10] EFFECTIVENESS OF AMPICILLIN AGAINST GRAM-NEGATIVE BACTERIA
    ANDERSON, KN
    PLORDE, JJ
    SHULMAN, JA
    PETERSDORF, RG
    KENNEDY, RP
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1964, 187 (08): : 555 - &